These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19724165)

  • 61. Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study.
    Kang JH; Keller JJ; Lin HC
    Osteoporos Int; 2013 Jan; 24(1):271-7. PubMed ID: 23152093
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke.
    Kang JH; Keller JJ; Lin HC
    Osteoporos Int; 2012 Oct; 23(10):2551-7. PubMed ID: 22270858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
    Zheng CM; Lu KC; Wu CC; Hsu YH; Lin YF
    Int J Nephrol; 2011; 2011():939613. PubMed ID: 21660259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation.
    Zhong X; Xiu LL; Wei GH; Liu YY; Su L; Cao XP; Li YB; Xiao HP
    Acta Pharmacol Sin; 2011 May; 32(5):591-600. PubMed ID: 21499286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral bisphosphonates and risk of ischemic stroke: a case-control study.
    Christensen S; Mehnert F; Chapurlat RD; Baron JA; Sørensen HT
    Osteoporos Int; 2011 Jun; 22(6):1773-9. PubMed ID: 20945149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Progress in the treatment of osteoporosis].
    Sugimoto T
    Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of bisphosphonates on lipid metabolism.
    Guney E; Kisakol G; Ozgen AG; Yilmaz C; Kabalak T
    Neuro Endocrinol Lett; 2008 Apr; 29(2):252-5. PubMed ID: 18404138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Androgens, cardiovascular disease and osteoporosis.
    Isidori AM; Giannetta E; Pozza C; Bonifacio V; Isidori A
    J Endocrinol Invest; 2005; 28(10 Suppl):73-9. PubMed ID: 16550728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bisphosphonates and atherosclerosis.
    Fiore CE; Pennisi P; Pulvirenti I; Francucci CM
    J Endocrinol Invest; 2009; 32(4 Suppl):38-43. PubMed ID: 19724165
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Bisphosphonates for vascular calcification].
    Tanaka Y; Okada Y
    Clin Calcium; 2007 Mar; 17(3):386-90. PubMed ID: 17339743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.